This brand name is authorized in Austria, Finland, Mexico, Netherlands, Singapore.
The drug PAMORELIN contains one active pharmaceutical ingredient (API):
1
|
UNII
08AN7WA2G0 - TRIPTORELIN PAMOATE
|
|
Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| L02AE04 | Triptorelin | L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 021820, 078476, 490552 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 123M97 |
| NL | Z-Index G-Standaard | 15046648, 15533212 |
| NL | Z-Index G-Standaard, PRK | 77615, 82554, 91820 |
| SG | Health Sciences Authority | 14323P, 14324P, 14325P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.